FDA, EMA accept application for talazoparib in metastatic breast cancer with inherited BRCA mutation

Tom Loughran tells us how he got UVA over the hump to comprehensive designation

The University of Virginia has taken a long, circuitous path to NCI comprehensive cancer center designation, but it got there.

November 19, 2021

Vol.47 No.43

By Paul Goldberg

ACS CAN wages state-by-state battle to expand access to biomarker testing

With growing evidence that molecular characterization of a tumor helps predict a patient’s prognosis and response to specific treatments, biomarker testing has been required or recommended for more than half of the 62 oncology drugs introduced over the past five years. However, health insurance policies don’t always cover tests, thus denying their clients access to precision medicine.

November 19, 2021

Vol.47 No.43

By Alice Tracey

Guest Editorial Health Equity

To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria

Emergent public-private partnerships (PPPs) have risen to the occasion to streamline and coordinate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. With these monumental efforts have come important public discussions about equitable access and representation in clinical trials (CTs).

November 19, 2021

Vol.47 No.43

By Julia Beaver, Thomas S. Uldrick, Gwynn Ison, Suanna S. Bruinooge, Caroline Schenkel and Edward S. Kim

Cancer History Project Conversation with The Cancer Letter

Patricia Ganz on how survivorship went from being an outlier to the mainstream

The National Coalition for Cancer Survivorship began in 1986 with 23 people at a hotel in Albuquerque and a $100 contribution from Patricia A. Ganz, who recalls thinking: “I don’t think I’ve ever invested in anything that was so good.”

November 19, 2021

Vol.47 No.43

By Alexandria Carolan

In the Archives

Cancer researchers, including Nobel laureates, center directors, gather at Nixon Library to mark 50th anniversary of the National Cancer Act

The Richard Nixon Foundation will host the Nixon National Cancer Conference at the Richard Nixon Presidential Library and Museum in Yorba Linda, CA, on Dec. 1-2.

November 19, 2021

Vol.47 No.43

In Brief

Bridget Oppong named deputy director of Ohio State’s Center for Cancer Health Equity

Bridget Oppong was named deputy director of the Center for Cancer Health Equity at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

November 19, 2021

Vol.47 No.43

FDA, EMA accept application for talazoparib in metastatic breast cancer with inherited BRCA mutation

YOU MAY BE INTERESTED IN

Tom Loughran tells us how he got UVA over the hump to comprehensive designation

ACS CAN wages state-by-state battle to expand access to biomarker testing

To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria

Patricia Ganz on how survivorship went from being an outlier to the mainstream

Cancer researchers, including Nobel laureates, center directors, gather at Nixon Library to mark 50th anniversary of the National Cancer Act

Bridget Oppong named deputy director of Ohio State’s Center for Cancer Health Equity

Renew today!

Subscriber content

Login